Zobrazeno 1 - 10
of 1 622
pro vyhledávání: '"Siddhanti S"'
Autor:
Roux, C., Hofbauer, L.C., Ho, P.R., Wark, J.D., Zillikens, M.C., Fahrleitner-Pammer, A., Hawkins, F., Micaelo, M., Minisola, S., Papaioannou, N., Stone, M., Ferreira, I., Siddhanti, S., Wagman, R.B., Brown, J.P.
Publikováno v:
In Bone January 2014 58:48-54
Autor:
Cummings, Sr, San Martin, J, Mcclung, Mr, Siris, Es, Eastell, R, Reid, Ir, Delmas, P, Zoog, Hb, Austin, M, Wang, A, Kutilek, S, Adami, S, Zanchetta, J, Libanati, C, Siddhanti, S, Christiansen, C, Freedom, Trial, Nuti, R
Publikováno v:
New England Journal of Medicine. 361:756-765
Denosumab is a fully human monoclonal antibody against the receptor activator of the cytokine, nuclear factor-κB ligand, which is of critical importance for the formation, function, and survival of osteoclasts. This antibody binds nuclear factor-κB
Publikováno v:
Journal of Chinese Pharmaceutical Sciences. Jul2024, Vol. 33 Issue 7, p587-596. 10p.
Autor:
Gudin J; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, New Jersey.; Pain Management and Wellness Center, Englewood, New Jersey., Rauck R; Carolinas Pain Institute and The Center for Clinical Research, Winston-Salem, North Carolina., Argoff C; Department of Neurology, Albany Medical Center, Albany, New York., Agaiby E; Clinical Investigation Specialists Inc, Kenosha, Wisconsin., Gimbel J; Arizona Research Center, Phoenix, Arizona., Katz N; Tufts University School of Medicine, Boston, Massachusetts.; *Analgesic Solutions, Wayland, Massachusetts., Doberstein SK; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Potts J; Great Lakes Research Group, Inc, Bay City, Michigan., Wild J; Upstate Clinical Research Associates, Williamsville, New York., Lu L; Nektar Therapeutics, San Francisco, California., Siddhanti S; Nektar Therapeutics, San Francisco, California., Hale M; Gold Coast Research, LLC, Plantation, Florida., Markman J; Department of Neurosurgery, Translational Pain Research Program, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Nov 07; Vol. 21 (7), pp. 1347-1356.
Autor:
Henningfield JE; Pinney Associates, Bethesda, Maryland., Gudin J; Englewood Hospital and Medical Center, Englewood, New Jersey., Rauck R; Carolinas Pain Institute and The Center for Clinical Research, Winston-Salem, North Carolina., Gimbel J; Arizona Research Center, Phoenix, Arizona., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Doberstein SK; Nektar Therapeutics, San Francisco, California., Di Fonzo C; Nektar Therapeutics, San Francisco, California., Lu L; Nektar Therapeutics, San Francisco, California., Katz N; Tufts University School of Medicine, Boston, Massachusetts.; Analgesic Solutions, Wayland, Massachusetts, USA., Siddhanti S; Nektar Therapeutics, San Francisco, California., Schnoll S; Pinney Associates, Bethesda, Maryland.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Aug 01; Vol. 21 (8), pp. 1553-1561.
Autor:
Ge X; Nektar Therapeutics, San Francisco, California., Henningfield JE; The Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, Maryland.; Pinney Associates, Bethesda, Maryland., Siddhanti S; Nektar Therapeutics, San Francisco, California., Jobes J; Nektar Therapeutics, San Francisco, California., Lu L; Nektar Therapeutics, San Francisco, California., Xie S; Nektar Therapeutics, San Francisco, California., Ziola M; Nektar Therapeutics, San Francisco, California., Kelsh D; Altasciences Clinical Research, Overland Park, Kansas, USA., Vince B; Altasciences Clinical Research, Overland Park, Kansas, USA., Di Fonzo CJ; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Zalevsky J; Nektar Therapeutics, San Francisco, California., Doberstein SK; Nektar Therapeutics, San Francisco, California., Hoch U; Nektar Therapeutics, San Francisco, California., Eldon MA; Nektar Therapeutics, San Francisco, California.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Feb 01; Vol. 21 (2), pp. e114-e126.
Publikováno v:
Osteoporosis International, 25, S128-S129
Annals of the Rheumatic Diseases, 73, 766-767
Annals of the Rheumatic Diseases, 73, 766-767
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f60287e5c8c9b93d9e3f10f71afc9ab7
http://hdl.handle.net/1887/108020
http://hdl.handle.net/1887/108020
Autor:
Geller, M., Wagman, R.B., Ho, P.R., Siddhanti, S., Stehman-Breen, C., Watts, N.B., Papapoulos, S.
Publikováno v:
Journal of Bone and Mineral Research, 29, S113-S113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::add6c163dfdd85c4f988737ed9d80222
http://hdl.handle.net/1887/101284
http://hdl.handle.net/1887/101284
Denosumab has been shown to reduce new vertebral, nonvertebral, and hip fractures in postmenopausal women with osteoporosis. In subjects who were treatment-naive or previously treated with alendronate, denosumab was associated with greater gains in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::29289c111c56c9601ff1500b8dae076b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3160292
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3160292
Publikováno v:
Journal of Mazandaran University of Medical Sciences (JMUMS). 2024, Vol. 34 Issue 234, p48-60. 13p.